Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens

Communications in Clinical Cytometry

Volumn 46, Issue 3, 2001, Pages 121-135

  Bagwell, C B ^a   Clark, G M ^a   Spyratos, F ^a   Chassevent, A ^b   Bendahl, P O ^c   Stal O ^d   Killander, D ^d   Jourdan, M L ^e   Romain, S ^f   Hunsberger, B ^g   Baldetorp, B ^h  

^a Verity Software House Inc   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CENTRE RENÉ HUGUENIN   (France)

^d CENTRE PAUL PAPIN   (France)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f LINKÖPING UNIVERSITY   (Sweden)

^g CHU BRETONNEAU   (France)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Breast cancer; DNA index; DNA ploidy; Flow cytometry; Prognosis; S phase

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SURVIVAL; DIAGNOSTIC VALUE; FLOW CYTOMETRY; GENETIC STABILITY; HUMAN; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; DATABASES, FACTUAL; DNA; FLOW CYTOMETRY; HUMANS; LYMPHATIC METASTASIS; MODELS, STATISTICAL; PLOIDIES; PROGNOSIS; S PHASE; TIME FACTORS;

EID: 0035875052     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.1097     Document Type: Article

References (70)

1. Rapid flow-cytofluorometric analysis of mammalian cell cycle by propidium iodide staining
2. Rapid, simultaneous measurement of DNA, protein, and cell volume in single cells from large mammalian cell populations
3. Mathematical analysis of DNA distributions derived from flow microfluorometry
4. Theoretical aspects of flow cytometry data analysis
5. Practical considerations for DNA content and cell cycle analysis
6. A method for dissociation of viable human breast cancer cells that produces flow cytometric kinetic information similar to that obtained by thymidine labeling
7. A proposed classification of breast cancer based on kinetic information. Derived from comparison of risk factors in 168 primary operable breast cancers
8. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors. Comparisons sons and correlations
9. Evaluation of S phase distribution of flow cytometric DNA histograms by autoradiography and computer algorithms
10. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry
11. Cellular DNA content as a marker of neoplasia in man
12. DNA in human tumors: A cytophotometric study
13. Flow cytometry in clinical cancer research
14. Clinical and biological significance of aneuploidy in human tumours
15. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors
16. Relevance of DNA-ploidy as a prognostic instrument for solid tumors
17. Cell proliferation kinetics in human solid tumors: Relation to probability of metastatic dissemination and long-term survival
18. DNA content in human cancer. Application in pathology and clinical medicine
19. Flow cytometric measurements of DNA and other components in human tumors: A critical appraisal
20. Prognostic applications of DNA analysis in solid malignant lesions in humans
21. DNA cytometry consensus conference
22. Breast cancer
23. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry
24. The prognostic significance of nuclear DNA content in invasive breast cancer: A study with long-term follow-up
25. Indicators of prognosis in node-negative breast cancer
26. S-phase fraction is a prognostic factor in stage I breast carcinoma
27. The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer
28. Prognostic significance of proliferative activity in node-negative breast cancer
29. DNA flow cytometry and pathologiC grading as prognostic guides in axillary lymph node-negative breast cancer
30. DNA ploidy and percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer
31. Biologic indicators of prognosis in breast cancer
32. Is DNA flow cytometry a useful investigation in breast cancer?
33. Prognostic indicators in node-negative breast cancer
34. S-phase fraction and breast cancer: A decade of experience
35. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
36. Clinical guidelines for the use of tumor markers in breast and colorectal cancer
37. Guidelines for implementation of clinical DNA cytometry
38. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens
39. Different calculation methods for flow cytometric S-phase fraction: Prognostic implications in breast cancer?
40. Picogram per cell determination of DNA by flow cytofluorometry
41. A detergent-trypsin method for the preparation of nuclei for flowcytometric DNA analysis
42. Convention on nomenclature for DNA cytometry
43. Regression models and life-tables
44. The resolution of aneuploid DNA stem lines by flow cytometry: Limitations imposed by the coefficient of variation and the percentage of aneuploid nuclei
45. Aneuploidy fraction bur not DNA index is important for the prognosis of patients with stage I and II breast cancer: 10-Year results
46. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
47. DNA content and survival in mammary carcinoma
48. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry
49. Flow cytometric DNA-histogram analysis: Non-stoichiometric fluorochrome binding and pseudoaneuploidy
50. Autolysis is a potential of false aneuploid peaks in flow cytometric DNA histograms
51. Evidence for false aneuploid peaks of paraffin-embedded tissue
52. Recognition and reduction of artifacts from autolysis in paraffin-embedded tissue using DNA/nuclear protein flow cytometry
53. Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer
54. Prognostìc value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer
55. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast cancer patients with long follow-up
56. DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma
57. The clonal evolution of tumor cell populations
58. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer
59. Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas
60. Proliferative index obtained by DNA image cytometry. Does ir add prognostic information in Auer IV breast cancer?
61. Flow cytometry in primary breast cancer: Improving the prognostic value of fraction of cells in the S-phase by optimal cathegorisation of cut-off levels
62. Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer
63. Automated peak detection and cell cycle analysis of flow cytometric DNA histograms
64. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer
65. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinoma by flow cytometry
66. Reproducibility in DNA flow cytometric analysis of breast cancer: Comparison of 12 laboratories' results for 67 sample homogenates
67. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: The Scandinavian Sarcoma Group Experience